Biologic evaluation of a novel 188re-labeled porphyrin in mice tumor model

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 1, 2010, Pages 47-54

  Sarma, Haladhar D ^a   Das, Tapas ^a   Banerjee, Sharmila ^a   Venkatesh, Meera ^a   Vidyasagar, Pandit B ^b   Mishra, Kaushala P ^c  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b UNIVERSITY OF PUNE   (India)

^c UNIVERSITY OF MUMBAI   (India)

Author keywords

Fibrosarcoma; Porphyrin; Targeted radiotherapy; Thymic lymphoma; Tumor regression

Indexed keywords

5,10,15,20 TETRAKIS[3,4 BIS(CARBOXYMETHYLENEOXY)PHENYL]PORPHYRIN RHENIUM 188; PORPHYRIN DERIVATIVE; RHENIUM 188; TUNGSTEN; UNCLASSIFIED DRUG; ORGANOMETALLIC COMPOUND; PORPHYRIN; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RHENIUM MESO-TETRAKIS(3,4-BIS(CARBOXYMETHYLENEOXY)PHENYL)PORPHYRIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TUMOR LEVEL; FEMALE; FIBROSARCOMA; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS LYMPHOMA; ANIMAL; CHEMISTRY; DISEASE MODEL; ISOTOPE LABELING; LYMPHOMA; METABOLISM; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PROCEDURES; THYMUS NEOPLASMS; TISSUE DISTRIBUTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FIBROSARCOMA; ISOTOPE LABELING; LYMPHOMA; MICE; NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; PORPHYRINS; RADIOISOTOPES; RADIOPHARMACEUTICALS; THYMUS NEOPLASMS; TISSUE DISTRIBUTION;

EID: 77649302505     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2009.0675     Document Type: Article

References (25)

1. Figge FHJ, Weiland GS, Manganiello LOJ. Cancer detection and therapy: Affinity of neoplastic, embryonic and traumatized tissues for porphyrin and metalloporphyrin. Proc Soc Exp Biol Med 1948;68:640.
2. Manganiello LOJ, Figge FHJ. Cancer detection and therapy. II: Methods of preparation and biological effects of metalloporphyrin. Bull School Med Univ Maryland 1951; 36:3.
3. Peck GC, Mack HP, Figge FHJ. Cancer detection and therapy. III: Affinity of lymphatic tissues for hematoporphyrin. Bull School Med Univ Maryland 1953;38:124.
4. Rasmussen-Taxdal DS, Ward GE, Figge FHJ. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer 1955;8:78.
5. Altman KF, Solomon K. Localization of a halogenated porphyrin in mouse tumour. Nature 1960;187:1124.
6. Lipson RL, Baldes EJ, Gray MS. Hematoporphyrin derivative for detection and management of cancer. Cancer 1967; 20:2255.
7. Fawwaz RA, Wang TST, Alderson PO. Evaluation of radioporphyrins as tumour seeking agents in experimental animals. J Nucl Med 1981;22:P50.
8. Kaye AH, Morstyn G, Apuzzo MLJ. Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg 1988;69:1.
9. Maziere JC, Santus R, Morliere P, et al. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low-and high-density lipoproteins. J Photo-chem Photobiol 1990;6:61.
10. Hambright P, Fawwaz RA, Valk P, et al. The distribution of various water-soluble radioactive metalloporphyrins in tumor bearing mice. Bioinorg Chem 1975;5:87.
11. Zanelli GD, Kaelin AD. Synthetic porphyrins as tumor localizing agents. Br J Radiol 1981;54:403.
12. Whelan HT, Kras LH, Ozker K, et al. Selective incorporation of 111In-labeled photofrin by glioma tissue in vivo. J Neurooncol 1994:22:7.
13. Bhalgat MK, Roberts JC, Mercer-Smith JA, et al. Preparation and biodistribution of copper-67-labeled porphyrins and porphyrn-A6H immunoconjugates. Nucl Med Biol 1997;24: 179.
14. Subbarayan M, Shetty SJ, Srivastava TS, et al. Evaluation studies of technetium-99m-porphyrin (T3,4BCPP) for tumor imaging. J Porphyr Phthalocya 2001;5:824.
15. 18F]fluorophenyl)10,15,20-tris (3-methoxyphenyl)porphyrin as a potential imaging agent for tumor. J Label Compd Radiopharm 2005;48:749.
16. Jia Z, Deng H, Pu M. Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice. Nucl Med Biol 2007;34: 643.
17. 109Pd] palladium labeled porphyrin for possible use in targeted radiotherapy. Radiochim Acta 2008;96:427.
18. Shetty SJ, Murugesan S, Chatterjee S, et al. A new 99mTc-labeled porphyrin for specific imaging of sarcoma 120: Synthesis and biological study in a Swiss mouse model. J Label Compd Radiopharm 1996;38:411.
19. 188Re]labelled porphyrin for targeted Radiotherapy. Nucl Med Commun 2001;22:1101.
20. Pillai MRA, Samuel G, Banerjee S, et al. Technetium-99m complexes of polydentate amine-pyrrole and amine-thiophene ligands. Nucl Med Biol 1999;26:69.
21. Fehlauer F, Muench M, Richter E, et al. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. Oncol Rep 2007;17:941.
22. Mehrara E, Forssell-Aronsson E, Ahlman H, et al. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 2007; 67:3970.
23. 99mTc-labeled dendritic novel porphyrins tumor imaging and diagnosis. Biochem Biophys Res Commun 2001; 281:32.
24. Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis. Exp Cell Res 1999;248:10.
25. Antoccia A, Banzato A, Bello M, et al. 188Rhenium-induced cell death and apoptosis in a panel of tumor cell lines. Nucl Instrum Meth A 2007;571:471.